Gene expression profiling and evaluation of physiologic functions in monocyte-derived multipotential cells
单核细胞来源的多能细胞的基因表达谱和生理功能评估
基本信息
- 批准号:15390307
- 负责人:
- 金额:$ 9.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have recently identified a novel CD14^+ CD45^+ CD34^+ type I collagen^+ cell fraction derived from human circulating CD14^+ monocytes, monocyte-derived multipotential cell (MOMC), which contains progenitors capable of differentiating into a variety of mesenchymal cells, including bone, cartilage, fat and skeletal muscle. To identify MOMC-related genes potentially involved in multipotentiality, gene expression profiling was compared between circulating monocytes and MOMCs by genechip analysis. Six genes, including DLG3, MyoX, SEPT3, EFNA3, ATF-1, and SAP30, were identified as genes preferentially expressed in the MOMC among monocyte-lineage cell types. Next, human MOMCs co-cultivated with primary cultures of rat cardiomyocytes or neurons underwent expression of cardiomyocyte- or neuron-specific transcription factors and structural proteins, respectively. MOMC-derived cardiomyocyte-like cells represented spontaneously beating, and exhibited electrophysiological properties of ventricul … More ar myocytes. MOMCs treated with angiogenic factors underwent a change in their morphology to caudated and upregulated expression of endothelium-specific molecules. Functional characteristics were indistinguishable between MOMC-derived endothelial cells and mature endothelial cells. In xenogenic transplantation studies using a SCID mouse model, in which syngeneic colon carcinoma were injected subcutaneously with human MOMCs, co-transplantation with MOMCs markedly promoted blood vessel formation. More than 50% of blood vessels incorporated human MOMC-derived endothelial cells. Finally, MOMCs were able to expand human hematopoietic stem cells to 100-fold in vitro in 2 weeks, but failed to maintain longterm-culture-initiating cells.The cellular therapy using MOMCs has considerable advantages over currently proposed strategies using tissue-specific stem cells and embryonic stem cells. Circulating monocytes can be an abundant and easily accessible source for autologous cell transplantation for tissue regeneration, and the ethical dilemma of using ES cells can be bypassed. Our findings suggest that strategies to use MOMCs can be one of practical alternatives to the stem cell-based regenerative therapies. Less
我们最近发现了一种新型 CD14^+ CD45^+ CD34^+ I 型胶原^+ 细胞组分,源自人类循环 CD14^+ 单核细胞,即单核细胞衍生的多能细胞 (MOMC),其中含有能够分化为多种细胞的祖细胞。间充质细胞,包括骨、软骨、脂肪和骨骼肌,为了识别可能参与多能性的 MOMC 相关基因,对循环之间的基因表达谱进行了比较。通过基因芯片分析,包括 DLG3、MyoX、SEPT3、EFNA3、ATF-1 和 SAP30 在内的 6 个基因被鉴定为在单核细胞谱系细胞类型中优先表达的基因。大鼠心肌细胞或神经元的原代培养物分别表达心肌细胞或神经元特异性转录因子和 MOMC 衍生的心肌细胞样细胞。 MOMC 来源的内皮细胞和成熟内皮细胞之间的功能特征无法区分。在使用 SCID 小鼠模型的异种移植研究中,其中同基因结肠癌皮下注射人 MOMC,与MOMCs共移植显着促进了血管形成,超过50%的血管融入了人类MOMC衍生的内皮细胞,最终,MOMCs能够在体外将人类造血干细胞扩增至100倍,但未能成功。维持长期培养起始细胞。与目前提出的使用组织特异性干细胞和胚胎干细胞的策略相比,使用 MOMC 的细胞疗法具有相当大的优势。且易于获得用于组织再生的自体细胞移植来源,并且可以绕过使用 ES 细胞的伦理困境。我们的研究结果表明,使用 MOMC 的策略可以成为基于干细胞的再生疗法的实用替代方案之一。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kuwana M, et al.: "Human circulating CD14^+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation"Journal of Leukocyte Biology. 74;5. 833-845 (2003)
Kuwana M等人:“人类循环CD14+单核细胞作为表现出间充质细胞分化的祖细胞的来源”白细胞生物学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Defective vasculogenesis in systemic sclerosis
- DOI:10.1016/s0140-6736(04)16853-0
- 发表时间:2004-08-14
- 期刊:
- 影响因子:168.9
- 作者:Kuwana, M;Okazaki, Y;Ikeda, Y
- 通讯作者:Ikeda, Y
A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies
一种在睾丸中高度表达的新型蛋白质在系统性硬化症成纤维细胞中过度表达并被自身抗体靶向
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Yasuoka H;Kuwana M;et al.
- 通讯作者:et al.
Kuwana M, et al.: "The effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura"Blood. 103;4. 1229-1236 (2004)
Kuwana M等人:“单次注射人源化抗CD154单克隆抗体对免疫性血小板减少性紫癜患者血小板特异性自身免疫反应的影响”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasuoka H, Kuwana M, et al.: "A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies"Journal of Immunology. 171;12. 6883-6890 (2003)
Yasuoka H、Kuwana M 等人:“一种在睾丸中高度表达的新型蛋白质在系统性硬化症成纤维细胞中过度表达,并被自身抗体靶向”《免疫学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUWANA Masataka其他文献
KUWANA Masataka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUWANA Masataka', 18)}}的其他基金
Development of novel strategies for treating systemic sclerosis focusing on circulating monocytes
开发治疗系统性硬化症的新策略,重点关注循环单核细胞
- 批准号:
26461471 - 财政年份:2014
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of bone marrow-derived cells in pathogenesis of pulmonary arterial hypertension associated with connective tissue diseases
骨髓源性细胞在结缔组织疾病相关肺动脉高压发病机制中的作用
- 批准号:
21390300 - 财政年份:2009
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of pathogenesis of systemic sclerosis based on dysfunctional endothelial progenitor cells and its application to novel therapeutic interventions
基于功能失调的内皮祖细胞的系统性硬化症发病机制分析及其在新型治疗干预中的应用
- 批准号:
19390275 - 财政年份:2007
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of Pathogenic Autoreactive T cells in Patients with Antiphospholipid Syndrome and its Application for Developing Specific Immune Therapies
抗磷脂综合征患者致病性自身反应性 T 细胞分析及其在开发特异性免疫疗法中的应用
- 批准号:
12557049 - 财政年份:2000
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
单核细胞通过THBS1-SDC4-MAPK信号轴激活Lox高表达成纤维细胞亚群并促进辐射诱导肺纤维化的机制研究
- 批准号:82304069
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α-MSH通过H3K4me3调控骨髓HSC分化为单核细胞促进炎性肠炎的机制研究
- 批准号:82302060
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
E3泛素连接酶NEDD4在异种肝移植术后单核细胞激活中的作用和机制研究
- 批准号:82371793
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
单核细胞分泌的Metrnl通过Kit受体介导血管内皮胞吞参与糖尿病视网膜病变的机制研究
- 批准号:82301238
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
- 批准号:
10751760 - 财政年份:2024
- 资助金额:
$ 9.54万 - 项目类别:
Feasibility of immunotherapy by ice-free cryopreservation of engineered human all
无冰冷冻保存工程化人类免疫治疗的可行性
- 批准号:
8250989 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Periodontal Biomaterials with BITE (Biofilm Immunity with Tissue Engineering)
具有 BITE(组织工程生物膜免疫)的牙周生物材料
- 批准号:
9005853 - 财政年份:2008
- 资助金额:
$ 9.54万 - 项目类别:
Global Analysis of Chromatin during Lineage Development
谱系发育过程中染色质的整体分析
- 批准号:
7881180 - 财政年份:2004
- 资助金额:
$ 9.54万 - 项目类别:
Global Analysis of Chromatin during Lineage Development
谱系发育过程中染色质的整体分析
- 批准号:
7455839 - 财政年份:2004
- 资助金额:
$ 9.54万 - 项目类别: